CorMedix (CRMD) Amortization of Deferred Charges (2010 - 2012)

CorMedix's (CRMD) quarterly Amortization of Deferred Charges came in at $76632.0 in Q4 2012, up 7663100.0% quarter-over-quarter from $1.0 in Q4 2010.

CorMedix (CRMD) Amortization of Deferred Charges (2010 - 2012) Analysis & Trends

CorMedix has disclosed Amortization of Deferred Charges across 2 years of filings, most recently posting $76632.0 for Q4 2012.

Amortization of Deferred Charges for Q4 2012 came in at $76632.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2013 was $76632.0 (up 7663100.0% YoY), and the FY2025 annual result was $398000.0, changed N/A from the prior year.
Amortization of Deferred Charges came in at $76632.0 for Q4 2012 at CorMedix, up from $1.0 in the prior quarter.
In the past five years, Amortization of Deferred Charges ranged from a high of $76632.0 in Q4 2012 to a low of $1.0 in Q4 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn
9	Abivax	91.71 Bn	91.71 Bn	-
10	CorMedix	631,378.03	-154.57 Mn	107.31 Mn

Download Data